Skip to main content
An official website of the United States government

Current NCI SBIR Contract Solicitation

Program Solicitation PHS 2024-1

Proposals due: Application Closed. FY24 solicitation coming summer 2023.


The FY24 SBIR Contract Solicitation topics are now available. See below for the 11 topics that will be included in this year's solicitation.

  • Ultra-Fast Dose Rate (FLASH) Radiation 
  • Technologies for Detecting Tumor-Derived Cell Clusters
  • Rapid and Affordable Point-of-Care HPV Diagnostics for Cervical Cancer Control
  • Translation of Novel Cancer-Specific Imaging Agents and Techniques to Mediate Successful Image-Guided Cancer Interventions
  • Microbiome-Based Tests for Cancer Research, Diagnosis, Prognosis, and/or Patient Management
  • Organ-on-Chip for Preclinical and Translational Radiobiological Studies
  • Point-of-Care Detection of Prostate Specific Antigen
  • Cancer Prevention and Treatment Clinical Trials Tools for Recruitment and Retention of Diverse Populations
  • Cloud-Based Multimodal Data Analysis Software for the Cancer Research Data Commons
  • Evaluation Datasets as Medical Device Development Tools for Testing Cancer Technologies
  • Automated Software for Point-of-Care Testing to Identify Cancer-Associated Malnutrition


Applicants must use the Contract Proposal Submission (eCPS) website to submit their proposal. No other method of proposal submission is permitted. Instructions for electronic submission are provided in the solicitation. Actual contract topic numbers will be available in the solicitation.

For more information, contact Cherie Wells, contract analyst in the Office of Acquisitions at

  • Updated:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Current NCI SBIR Contract Solicitation was originally published by the National Cancer Institute.”